AFP and neoplasm: However, in 2015, the system was revised so that T2 patients are not given the exceptional MELD-Na score until a 6-month mandatory period after enrollment, and a MELD-Na score of 28 points is given after 6 months if the tumor meets the Milan criteria with alpha-fetoprotein (AFP) below a certain level [9].